Aegerion Files Ch. 11, Plans $400M Sale To Amryt Pharma
Embattled specialty drug company Aegerion has filed for bankruptcy with plans to sell itself to Amryt Pharma PLC for $400 million, a move that comes one year after the company pled...To view the full article, register now.
Already a subscriber? Click here to view full article